Clinical trials
Lung clinical trials
Below are recruiting lung clinical trials, each written for real people, not researchers. We’re tracking 2,911 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06840288Recruiting
Lung tumor ablation registry study
This study tracks patients with small lung tumors that are treated with a robotic bronchoscope to destroy the tumor using heat. It aims to learn how well this procedure works over time.
Houston, TexasAges 18 years+ - NCT06791798Recruiting
Breathing treatments for patients on ventilators
This study tests two breathing treatments—ventilator hyperinflation and chest vibration—to see which works better for clearing mucus and improving lung function in people who have been on a breathing machine for 2 to 7 days.
CairoAges 35–55 - NCT06786728Enrolling by invitation
Ultrasound-guided fluid removal for kidney recovery in heart-kidney syndrome
This study tests if using ultrasound scans to guide fluid removal helps protect kidney function in people with cardiorenal syndrome type 1, where heart failure suddenly worsens kidney function.
CairoAges 18–65 - NCT06825715Recruiting
Precision oncology support for lung and prostate cancer
This study tests a program to help veterans with lung or prostate cancer get personalized cancer treatments. The goal is to see if extra support for doctors and patients leads to better use of precision medicine.
New York, New YorkAges Any age - NCT06769360Recruiting
Pressure support breathing trial for ICU patients
This trial tests a new way to set the breathing machine's pressure support based on your muscle effort. It may help you breathe more comfortably and improve recovery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06775275RecruitingPhase 2
Testing adebrelimab plus chemo before lung cancer surgery
This trial tests a new drug (adebrelimab) combined with standard chemotherapy, with or without another drug (bevacizumab), given before surgery for people with a certain type of lung cancer. The goal is to see if this combination helps shrink the tumor and makes surgery more effective.
GuangzhouAges 18–65 - NCT06675942Recruiting
Comparing two breathing techniques for patients with excess mucus on ventilators
This trial compares two chest therapy methods to help clear mucus in ICU patients who are on a breathing machine. If you have a lot of mucus and are on a ventilator, this study may test which technique works better.
BeijingAges 18 years+ - NCT06595602Recruiting
Intelligent lung support in the ICU
This trial tests a smart breathing machine that adjusts support automatically for people on a ventilator. It may help make breathing more comfortable and reduce lung injury.
DresdenAges 18 years+ - NCT06362980RecruitingPhase 1
BPI-1178 plus osimertinib for EGFR-mutated lung cancer
This trial tests a new drug (BPI-1178) combined with osimertinib for advanced lung cancer with EGFR mutations. It’s for people whose cancer has progressed after prior treatment with a third-generation EGFR targeted therapy.
BeijingAges 18 years+ - NCT06479252Recruiting
Comparing ways to test sit-to-stand in chronic lung disease
This study compares three ways of doing a simple sit-to-stand test for people with chronic lung disease: at the clinic, at home with video supervision, or on your own at home. The goal is to see which option works best and is easiest for patients.
Toronto, OntarioAges 18 years+ - NCT06181929Recruiting
Early lung cancer detection in Korean women with family history
This study looks at a new way to find lung cancer early in Korean women who have never smoked but have a family history of lung cancer. You would get a special CT scan (low-dose CT) to check for early signs of cancer, which could help catch it sooner.
Seoul, SeoulAges 45–74 - NCT06179069RecruitingPhase 1
Study of ZL-1310 for small cell lung cancer
This trial tests a new drug called ZL-1310, alone or with other treatments, for people with small cell lung cancer that has spread (extensive-stage). It aims to see if ZL-1310 can help shrink tumors or slow the disease.
Duarte, CaliforniaAges 18 years+ - NCT06286891Recruiting
Frailty and lung function after pulmonary endarterectomy
This study looks at how frailty, physical ability, and lung function change in people who have had surgery to remove blood clots from the lungs (pulmonary endarterectomy). It aims to help doctors better understand recovery after this procedure.
São Paulo, São PauloAges 18 years+ - NCT06296277Recruiting
Breathing machine use during surgery
This study looks at how a breathing machine is used during surgery. It is for adults who need help breathing while under general anesthesia for their operation.
Alessandria, ItalyAges 18 years+ - NCT05971719Recruiting
Testing an air “sniffer” using aerosol glycerine during lung surgery
This trial checks whether a new system can detect and pinpoint tiny air leaks during lung transplant surgery. It uses a glycerine mist during the operation, which may help surgeons find leaks and repair them sooner.
MontrealAges 18 years+ - NCT06037733Recruiting
Focused radiation to main tumor after chemo-immunotherapy for lung cancer
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
Wuhan, HubeiAges 18–75 - NCT06083870RecruitingPhase 1
Oba01 for advanced lung cancer that has progressed
This trial tests a new drug called Oba01 for people with advanced non-small cell lung cancer (NSCLC) that has gotten worse after other treatments. It targets a protein called DR5 found on cancer cells.
ShanghaiAges 18–75 - NCT06120803RecruitingPhase 2
Esomeprazole for preventing radiation-induced esophagitis
This study tests whether a common heartburn medicine (esomeprazole) can help prevent or reduce painful swallowing caused by radiation for lung cancer. If you have stage 3 non-small cell lung cancer and are getting chemo and chest radiation, you may be able to join.
Chicago, IllinoisAges 18 years+ - NCT06092086RecruitingPhase 2
Lorlatinib for first-line treatment of ALK-positive lung cancer
This trial tests a targeted pill, lorlatinib, for people with advanced ALK-positive non-small cell lung cancer (NSCLC) who have not received previous treatment for advanced disease. It aims to see how well the drug works in this setting.
Guangzhou, GuangdongAges 18 years+ - NCT06125041RecruitingPhase 2
Adebelizumab with chemo and radiation for advanced lung cancer
This trial tests a new drug called Adebelizumab (an immunotherapy) combined with chemotherapy and radiation for people with extensive stage small cell lung cancer. The goal is to see if this combination helps shrink tumors and improves survival.
Jinan, ShandongAges 18–75 - NCT05778253Recruiting
Blood and AI pathology to guide treatment in resectable lung cancer
This study checks whether special blood testing plus computer-based review of tumor slides can help plan care for lung squamous cell cancer that can be removed by surgery. It looks at patients who have not had prior cancer treatment and who meet specific stage and health criteria.
Changsha, HunanAges 18–75 - NCT05664204Recruiting
ECMO before or after lung transplant to improve outcomes
This study looks at using a heart–lung machine (ECMO) to reduce complications and deaths after a lung transplant. It focuses on people getting a lung transplant who have certain types of lung-vessel (pulmonary) pressure problems.
ParisAges 18 years+ - NCT05627674Enrolling by invitation
Help improve lung cancer screening and quitting support uptake
This study tests a “precision” approach to help people who are newly eligible for lung cancer screening actually get screened and start smoking-cessation treatment. If it works, it could make screening and quitting help easier to access and more engaging.
St Louis, MissouriAges 18 years+ - NCT05470686Recruiting
Heart surgery patients: link oxygen levels to lung ultrasound
This study checks how well a lung ultrasound score matches oxygen levels after heart surgery. It may help clinicians monitor breathing problems using ultrasound and guide non-drug breathing and therapy care.
Vandœuvre-lès-NancyAges 18 years+
Hear when a new Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lung?
- Yes. Clin2 currently lists 2,911 recruiting lung studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lung trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lung trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.